Cite
HARVARD Citation
Gasparetto, C. et al. (2021). Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma. EJHaem. 2 (1), pp. 56-65. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gasparetto, C. et al. (2021). Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma. EJHaem. 2 (1), pp. 56-65. [Online].